170 related articles for article (PubMed ID: 11301393)
1. Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma.
Satgé D; Monteil P; Sasco AJ; Vital A; Ohgaki H; Geneix A; Malet P; Vekemans M; Réthoré MO
Cancer; 2001 Apr; 91(8):1458-66. PubMed ID: 11301393
[TBL] [Abstract][Full Text] [Related]
2. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
3. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
Perry A; Aldape KD; George DH; Burger PC
Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
[TBL] [Abstract][Full Text] [Related]
4. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
[TBL] [Abstract][Full Text] [Related]
5. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature.
Satgé D; Sasco AJ; Curé H; Leduc B; Sommelet D; Vekemans MJ
Cancer; 1997 Sep; 80(5):929-35. PubMed ID: 9307193
[TBL] [Abstract][Full Text] [Related]
6. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
[TBL] [Abstract][Full Text] [Related]
7. [Classification of the astrocytic gliomas. Brief comments].
Pérez-Ortiz L; Galarraga J; Gómez-Suárez H; Tamayo-Suárez JD
Rev Neurol; 2000 Dec 16-31; 31(12):1180-3. PubMed ID: 11205555
[TBL] [Abstract][Full Text] [Related]
8. [Molecular pathology of brain tumors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2005; 122(1):191-6. PubMed ID: 16173698
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
12. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.
Kunwar S; Mohapatra G; Bollen A; Lamborn KR; Prados M; Feuerstein BG
Cancer Res; 2001 Oct; 61(20):7683-8. PubMed ID: 11606412
[TBL] [Abstract][Full Text] [Related]
13. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.
Krupp W; Geiger K; Schober R; Siegert G; Froster UG
Cancer Genet Cytogenet; 2004 Aug; 153(1):32-8. PubMed ID: 15325091
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
18. 10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IV.
Wessels PH; Twijnstra A; Kubat B; Ummelen MI; Claessen SM; Sciot R; Merlo A; Ramaekers FC; Speel EJ; Hopman AH
Genes Chromosomes Cancer; 2004 Jan; 39(1):22-8. PubMed ID: 14603438
[TBL] [Abstract][Full Text] [Related]
19. Sudden death due to primary intracranial neoplasms. A forensic autopsy study.
Vougiouklakis T; Mitselou A; Agnantis NJ
Anticancer Res; 2006; 26(3B):2463-6. PubMed ID: 16821633
[TBL] [Abstract][Full Text] [Related]
20. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
